608 related articles for article (PubMed ID: 29926308)
1. Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.
Liu F; Wang C; Gao Y; Li X; Tian F; Zhang Y; Fu M; Li P; Wang Y; Wang F
Mol Diagn Ther; 2018 Oct; 22(5):551-569. PubMed ID: 29926308
[TBL] [Abstract][Full Text] [Related]
2. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
Bolhassani A; Milani A
Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
[TBL] [Abstract][Full Text] [Related]
3. Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy.
Huang PI; Lo WL; Cherng JY; Chien Y; Chiou GY; Chiou SH
Curr Gene Ther; 2012 Aug; 12(4):275-84. PubMed ID: 22856602
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
[TBL] [Abstract][Full Text] [Related]
5. siRNA delivery systems for cancer treatment.
Oh YK; Park TG
Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
[TBL] [Abstract][Full Text] [Related]
6. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
Hong CA; Nam YS
Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
[TBL] [Abstract][Full Text] [Related]
7. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based delivery system for application of siRNA in vivo.
Wang Y; Li Z; Han Y; Liang LH; Ji A
Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in development of siRNA delivery vehicles for cancer therapy.
Kim HJ; Kim A; Miyata K; Kataoka K
Adv Drug Deliv Rev; 2016 Sep; 104():61-77. PubMed ID: 27352638
[TBL] [Abstract][Full Text] [Related]
10. Delivery strategies and potential targets for siRNA in major cancer types.
Lee SJ; Kim MJ; Kwon IC; Roberts TM
Adv Drug Deliv Rev; 2016 Sep; 104():2-15. PubMed ID: 27259398
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic siRNA: principles, challenges, and strategies.
Gavrilov K; Saltzman WM
Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
[TBL] [Abstract][Full Text] [Related]
12. Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy.
Wahane A; Waghmode A; Kapphahn A; Dhuri K; Gupta A; Bahal R
Molecules; 2020 Jun; 25(12):. PubMed ID: 32580326
[TBL] [Abstract][Full Text] [Related]
13. Journey of siRNA: Clinical Developments and Targeted Delivery.
Nikam RR; Gore KR
Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy.
Zhang J; Chen B; Gan C; Sun H; Zhang J; Feng L
Int J Nanomedicine; 2023; 18():7605-7635. PubMed ID: 38106451
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic face of RNAi: in vivo challenges.
Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
[TBL] [Abstract][Full Text] [Related]
16. Interfering with disease: opportunities and roadblocks to harnessing RNA interference.
Lieberman J; Song E; Lee SK; Shankar P
Trends Mol Med; 2003 Sep; 9(9):397-403. PubMed ID: 13129706
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances of Polycationic siRNA Vectors for Cancer Therapy.
Bholakant R; Qian H; Zhang J; Huang X; Huang D; Feijen J; Zhong Y; Chen W
Biomacromolecules; 2020 Aug; 21(8):2966-2982. PubMed ID: 32568525
[TBL] [Abstract][Full Text] [Related]
18. Cationic lipids and polymers mediated vectors for delivery of siRNA.
Zhang S; Zhao B; Jiang H; Wang B; Ma B
J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
[TBL] [Abstract][Full Text] [Related]
19. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral-mediated delivery of siRNAs for antiviral therapy.
Morris KV; Rossi JJ
Gene Ther; 2006 Mar; 13(6):553-8. PubMed ID: 16397511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
